title: Targeting a cystic fibrosis mutation opens door for personalized treatment.
authors.affiliation: Genentech. TMorrow@ManagedCareMag.com
authors.forename: Thomas
authors.initials: T
authors.lastname: Morrow
mesh_terms: D000627:Aminophenols / Q000009:adverse effects / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D057285:Precision Medicine; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States
chemical_list: D000627:Aminophenols; D015363:Quinolones; C545203:ivacaftor